🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Ovarian Cancer Metastatic

Access to Genetic Testing in Underserved Patients With Cancer NCT06422455NA2 sites📍 Los Angeles📍 Rochester University of Southern California · Tests: Best Practice, Educational Intervention, Electronic Health Record Review, Genetic Counseling, Interview A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies NCT05803018Phase 1, Phase 21 site📍 Shanghai Sichuan Baili Pharmaceutical Co., Ltd. · Tests: BL-B01D1 Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy NCT07144826EARLY Phase 11 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Biospecimen Collection, Placebo Administration, Probiotic, Questionnaire Administration A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) NCT05429970NA7 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Mind-body resilience training, Music therapy, Propranolol, Etodolac Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial NCT07158021Phase 21 site📍 Ann Arbor University of Michigan Rogel Cancer Center · Tests: Biospecimen Collection, Electronic Health Record Review, Goserelin, Leuprolide, Questionnaire Administration A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites📍 Los Angeles📍 Los Angeles📍 Whittier Daiichi Sankyo · Tests: Ifinatamab deruxtecan Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors NCT06666270Phase 12 sites📍 Zhengzhou📍 Shanghai Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd · Tests: SYN818 A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors NCT06533332Phase 15 sites📍 Ryde📍 Sydney📍 Westmead EtiraRx Australia Pty Ltd · Tests: ERX-315 A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors NCT07115043Phase 1, Phase 213 sites📍 Grand Rapids📍 St Louis📍 Pittsburgh AstraZeneca · Tests: AZD6750, rilvegostomig A Study of NX-1607 in Adults With Advanced Malignancies NCT05107674Phase 117 sites📍 Duarte📍 Los Angeles📍 San Francisco Nurix Therapeutics, Inc. · Tests: NX-1607, Paclitaxel Disitamab Vedotin Combined With Platinum and Bevacizumab as First-Line and Maintenance Therapy for HER2-Expressing, HRD-Negative High-Risk Ovarian Cancer: A Multicenter, Non-Randomized, Single-Arm Phase II Clinical Study NCT07311577Phase 22 sites📍 Nanjing📍 Nanjing Jiangsu Cancer Institute & Hospital · Tests: RC48+Carboplatin+Bevacizumab Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer NCT06463028Phase 218 sites📍 La Jolla📍 San Francisco📍 Miami Beach Faeth Therapeutics · Tests: Sapanisertib, Serabelisib, Paclitaxel EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EBNK-001 + IL-15 + Pembrolizumab Survivors Uniting for Remote Guided Exercise NCT07290309NA1 site📍 Fort Collins Colorado State University · Tests: Virtually Supervised Exercise Sessions, Asynchronous Group A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations NCT07610798Phase 1, Phase 21 site📍 Guangzhou Shenzhen Ionova Life Sciences Co., Ltd. · Tests: INV-8989 Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) NCT05579366Phase 1, Phase 266 sites📍 Phoenix📍 Tucson📍 Los Angeles Genmab · Tests: Rina-S, Carboplatin, Bevacizumab, Pembrolizumab, Erythromycin A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors NCT06769152Phase 21 site📍 Ji'nan Shanghai Henlius Biotech · Tests: HLX43 Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer NCT07718854Phase 21 site📍 Boston Tufts Medical Center · Tests: Sacituzumab tirumotecan, Pembrolizumab A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors NCT06465069Phase 139 sites📍 Duarte📍 La Jolla📍 Los Angeles Eli Lilly and Company · Tests: LY4052031, Pembrolizumab Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer NCT07171528Phase 21 site📍 Goyang-si National Cancer Center, Korea · Tests: Secondary Cytoreductive Surgery Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib NCT03651206Phase 2, Phase 336 sites📍 Angers📍 Besançon📍 Bordeaux ARCAGY/ GINECO GROUP · Tests: Niraparib, Niraparib + TSR-042 (Dostarlimab), Chemotherapy Drugs Comprehensive Outcomes for After Cancer Health NCT05349227NA7 sites📍 Gainesville📍 Boston📍 Omaha Pack Health · Tests: Digital Health Coaching Program, Fitbit Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer NCT06580314Phase 3695 sites📍 Birmingham📍 Anchorage📍 Anchorage NRG Oncology · Tests: Bevacizumab, Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Olaparib Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression NCT06839144Phase 22 sites📍 Ramat Gan📍 Tel Aviv Tel-Aviv Sourasky Medical Center · Tests: Propranolol (Beta-Blocker) and Etodolac (COX-2 Inhibitor), Placebo (Matching for Propranolol & Etodolac) A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors NCT04657068Phase 1, Phase 288 sites📍 Birmingham📍 Scottsdale📍 Little Rock Artios Pharma Ltd · Tests: ART0380, Gemcitabine, Irinotecan DBC-664 in Adult Patients With Solid Tumors NCT07705035Phase 17 sites📍 Denver📍 Grand Rapids📍 St Louis Duboce Biopharmaceuticals, Inc. · Tests: DBC-664 Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours NCT05427487Phase 13 sites📍 Sydney📍 Adelaide📍 Melbourne ImmVirx Pty Ltd · Tests: IVX037, Sintilimab Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial NCT04575935Phase 319 sites📍 Miami📍 Weston📍 Boston M.D. Anderson Cancer Center · Tests: Chemotherapy, Laparotomy, Minimally Invasive Surgery, Quality-of-Life Assessment, Questionnaire Administration A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer NCT07213804Phase 3265 sites📍 Birmingham📍 Phoenix📍 Burbank Eli Lilly and Company · Tests: Sofetabart Mipitecan, Paclitaxel, Topotecan, Gemcitabine, Pegylated liposomal doxorubicin (PLD) Measuring Oncological Value of Exercise and Statin NCT05796973Phase 31 site📍 Tampere Tampere University Hospital · Tests: Guided physical exercise, Atorvastatin, Independent exercise
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy